Table 3.
Association between baseline AGR and all-cause and cardiovascular mortality
| All-cause mortality | Cardiovascular mortality | |||
|---|---|---|---|---|
| HR(95%CI) | p | HR(95%CI) | p | |
| Unadiusted | ||||
| AGR ≤ 1.25 vs | 2.50 (1.72–3.63) | < 0.001 | 2.88 (1.62–5.14) | < 0.001 |
| AGR > 1.26 | 1 | 1 | ||
| Model 1a | ||||
| AGR ≤ 1.25 vs | 1.80 (1.24–2.62) | 0.002 | 2.18 (1.22–3.91) | 0.009 |
| AGR > 1.26 | 1 | 1 | ||
| Model 2b | ||||
| AGR ≤ 1.25 vs | 1.57 (1.07–2.32) | 0.022 | 2.01 (1.10–3.69) | 0.023 |
| AGR > 1.26 | 1 | 1 | ||
Abbreviations: AGR = Albumin-globulin ratio, HR = Hazard ratio, CCI = Charlson comorbidity index, RDW = Red cell distribution width, 95%CI = 95% Confidence interval
a Adjusted for sex and CCI
bAdjusted for model1 covariates and leukocytes, hemoglobin, platelet, RDW, phosphorus, albumin-corrected calcium, serum creatinine, urea nitrogen, serum uric acid, peritoneal dialysate glucose concentration